Home
>
National Drug Code (NDC)
>
VUMON
VUMON - 0015-3075-19 - (TENIPOSIDE)
Drug Information of VUMON
| Product NDC: | 0015-3075 |
| Proprietary Name: | VUMON |
| Non Proprietary Name: | TENIPOSIDE |
| Active Ingredient(s): | 10 mg/mL & nbsp; TENIPOSIDE |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of VUMON
| Product NDC: | 0015-3075 |
| Labeler Name: | E.R. Squibb & Sons, L.L.C. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020119 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19920714 |
Package Information of VUMON
| Package NDC: | 0015-3075-19 |
| Package Description: | 1 AMPULE in 1 CARTON (0015-3075-19) > 5 mL in 1 AMPULE |
NDC Information of VUMON
| NDC Code | 0015-3075-19 |
| Proprietary Name | VUMON |
| Package Description | 1 AMPULE in 1 CARTON (0015-3075-19) > 5 mL in 1 AMPULE |
| Product NDC | 0015-3075 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | TENIPOSIDE |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19920714 |
| Marketing Category Name | NDA |
| Labeler Name | E.R. Squibb & Sons, L.L.C. |
| Substance Name | TENIPOSIDE |
| Strength Number | 10 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
